The reason Biogen's Alzheimer's drug is priced at $56,000 per year and not $112,000 is because they are being kind.

Nothing in the law or process that prevents them from setting whatever price they want. The system is not broken. There is no system.
Hope people at recent @icer_review meeting remember the comment I made at the myeloma meeting: Pharma is wary about lawmakers going after them for price increases. So the name of the game is going to be front loading. Get all you can get early.

@SarahKarlin @RESachs @DusetzinaS
Please for heaven's sake pass a law enabling Medicare to directly negotiate prescription drug prices. 90% of the public wants it.
See below how the transfer of wealth occurs.

• • •

Missing some Tweet in this thread? You can try to force a refresh
 

Keep Current with Vincent Rajkumar

Vincent Rajkumar Profile picture

Stay in touch and get notified when new unrolls are available from this author!

Read all threads

This Thread may be Removed Anytime!

PDF

Twitter may remove this content at anytime! Save it as PDF for later use!

Try unrolling a thread yourself!

how to unroll video
  1. Follow @ThreadReaderApp to mention us!

  2. From a Twitter thread mention us with a keyword "unroll"
@threadreaderapp unroll

Practice here first or read more on our help page!

More from @VincentRK

8 Jun
Incidental COVID positive test after full vaccination without COVID symptoms is not COVID.

Better still I have been calling for Reinfection COVID and Post vaccination COVID to have their own names, because the natural history and prognosis will be different.
COVID is the name of a disease: SARS CoV-2 infection in people without prior immunity to SARS CoV-2 infection. It carried a certain hospitalization / mortality rate.

SARS CoV-2 infection in people who previously had COVID or were fully vaccinated are different diseases.
You have to define the natural history of each separately because both for the individual patient and for public policy the implications are different.

It doesn't mean Post Vaccination COVID cant be serious: it means the prognosis from such diagnosis will be different from COVID
Read 4 tweets
7 Jun
The FDA basically has the stance that as long as efficacy and safety are shown, the magnitude of the clinical benefit, no matter how tiny, doesn't matter. The cost however huge doesn't matter. It's not in their purview.

We need to reform the system.
nytimes.com/2021/06/07/hea…
In all other developed countries, regulatory approval is only the first of two steps.

I believe with existing law, CMS and insurance companies can play hardball and exercise the second step: Value. It would be better still if we had an automatic second step to assess value.
We are going to spend money we don't have. We are going to spend money that can go for other life saving treatments. No country has infinite resources.
Read 4 tweets
7 Jun
Important study on relative efficacy of COVISHIELD versus COVAXIN in India. @singhak_endo

Quite a difference in seropositivity after one dose. Difference narrows after 2 doses.

Get whichever vaccine you are offered first. Make sure you get both doses. medrxiv.org/content/10.110…
Note that they didn't use neutralizing antibody test. But the results reported should still have a high degree of correlation.

Second, there is more to immunity than antibody titers. However, we do have data that neutralizing antibody levels do correlate with clinical efficacy.
What does this mean: After 1 dose, COVAXIN may not be as effective as COVISHIELD. Thankfully, 2nd dose of COVAXIN is given 4-6 weeks after first. Make sure to get the 2nd dose. After 2 doses, you have an excellent chance of the body being able to fight & destroy the COVID virus.
Read 5 tweets
6 Jun
Based on what we know so far about the COVID delta variant, and what's happening in the UK, 40% of population fully vaccinated is NOT sufficient protection.

See below. The rise in cases in the UK is more apparent in log scale. It's worrying. #GetVaccinated
#GetFullyVaccinated ImageImage
In the US, 30 million need to make sure they get their second dose.

Another 60-100 million need to be fully vaccinated.
Here is why I'm worried about the B1.617 family, including the delta variant (B.1.617.2).

It is a triple threat: More transmissible, reduced vaccine efficacy, and likely more virulent.
It's better to be safe.
Read 4 tweets
5 Jun
Dr. Fauci has a H index of 227.

Which means he has 227 papers that have been cited 227 times or more. There are few people in the history of medicine who have a higher H index. It speaks to how much he has contributed to medicine.

Be respectful. Image
Let me add that 99.9% of academics on Twitter don't have a H index >150. Let alone 200+
@EricTopol is the only one I know in the 200+ range.

The higher the H index, the harder it is to increase it by even one point.
Read 4 tweets
2 Jun
You don't get much credit for editorials in academic promotions. But I have found them quite useful to advance a new concept, make an argument for change, or for advocacy. #MedTwitter

Here are 5 editorials that I hope highlight how you can make it work.

See thread.
1/ Redefining Myeloma
We wrote this to make the case that the disease definition for multiple myeloma was outdated, and made suggestions on how it should be revised. Few years later the definition was changed. @NatRevClinOncol @DianaNrco
nature.com/articles/nrcli…
2/ Strategic Clinical Trials
In this editorial, we called for disclosure of the true purpose of a clinical trial which is often different than the primary objectives, & also for strategic investigator initiated randomized trials. @TheLancet @jocalynclark thelancet.com/journals/lance…
Read 6 tweets

Did Thread Reader help you today?

Support us! We are indie developers!


This site is made by just two indie developers on a laptop doing marketing, support and development! Read more about the story.

Become a Premium Member ($3/month or $30/year) and get exclusive features!

Become Premium

Too expensive? Make a small donation by buying us coffee ($5) or help with server cost ($10)

Donate via Paypal Become our Patreon

Thank you for your support!

Follow Us on Twitter!

:(